Market Tracker

01/29 6:05pm ET

Salix Pharmaceuticals Ltd (NASDAQ:SLXP)

During the Trading Day
135.14 +7.25 / +5.67%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
135.14 0.00 / 0.00%
 
Volume: 53.3K

Today’s Trading

Previous close127.89
Today’s open132.80
Day’s range131.00 - 137.61
Volume2,789,004
Average volume (3 months)2,417,040
Market cap$8.1B
Dividend yield--
Data as of 3:59pm ET, 01/29/2015

Growth & Valuation

Earnings growth (last year)+115.84%
Earnings growth (this year)+7.84%
Earnings growth (next 5 years)+24.00%
Revenue growth (last year)+26.98%
P/E ratioNM
Price/Sales5.95
Price/Book10.86

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc+3.69+3.54%
IDXXIDEXX Laboratories I...+1.19+0.74%
TAROTaro Pharmaceutical ...+0.82+0.50%
UTHRUnited Therapeutics ...-1.54-1.07%
Data as of 4:03pm ET, 01/29/2015

Financials

Next reporting dateFebruary 26, 2015
EPS forecast (this quarter)-$0.10
Annual revenue (last year)$933.8M
Annual profit (last year)$143.0M
Net profit margin15.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Carolyn J. Logan
CFO, Senior VP-Finance &
Administrative Services
Timothy J. Creech
Corporate headquarters
Raleigh, North Carolina

Forecasts